Gene editing as treatment for coronary heart disease

“Verve is developing one-time gene editing medicines that safely edit the adult human genome and mimic naturally-occurring cardioprotective variants to permanently knock out cholesterol-raising genes in the liver and treat coronary heart disease.” learn more

Leave a Reply

Your email address will not be published. Required fields are marked *